Immune-Related Adverse Events: Pneumonitis

Research output: Chapter in Book/Report/Conference proceedingChapter

31 Scopus citations

Abstract

Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns. The goal of this chapter is to instruct readers on the incidence and clinical manifestations of pneumonitis and to offer guidance in the evaluation and treatment of patients with pneumonitis.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer
Pages255-269
Number of pages15
DOIs
StatePublished - 2020

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1244
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Checkpoint inhibitors
  • Diffuse alveolar damage
  • Hypersensitivity pneumonitis
  • Immune-related adverse event
  • Nonspecific interstitial pneumonia
  • Organizing pneumonia
  • Pneumonitis
  • Thoracic imaging

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Immune-Related Adverse Events: Pneumonitis'. Together they form a unique fingerprint.

Cite this